GenEdit's core technologies have been published in top science journals - Nature Materials and Nature Biomedical Engineering - and featured in science news media. 



The biggest challenge of CRISPR/Cas9 field is a delivery problem. GenEdit provides a new approach solving the problem with safe and efficient technology.


CRISPR-Gold, nonviral nanoparticle delivery for CRISPR, developed by GenEdit is made up of gold nanoparticles combined with DNA. 


Researchers have found a way to deliver gene-activating molecules called transcription factors into specific tissues of a living animal for the first time.